Navigation Links
UK is first to administer new anti-clotting technology

Volunteers at the Jack and Linda Gill Heart Institute at the University of Kentucky were the first ever to receive a new anti-clotting therapy. The drug and its antidote are being developed for their effectiveness in preventing blood clots while at the same time providing physicians the ability to rapidly reverse the effects of the blood thinner to help safeguard patients against uncontrolled bleeding.

More than 12 million patients are prescribed so-called "blood thinners" each year to prevent the formation of clots, which can block blood vessels, causing heart attacks, strokes and other debilitating or life-threatening conditions. Blood thinners, or antithrombotics, pose a risk of bleeding, particularly during surgery. The ability to stop the anti-clotting effects quickly could help protect patients from uncontrolled bleeding.

The Gill Heart Institute is one of two sites participating in the Phase 1 trial and is the first site to use the anti-clotting drug and its antidote.

This clinical trial will examine the drug's safety and tolerability in healthy volunteers as well as the antidote's ability to quickly reverse its effects. Although other new antithrombotics are undergoing testing in the U.S., this drug is believed to be the first of its kind.

"This class of drugs is a very promising technology that allows for the development of 'designer' drugs and their antidotes simultaneously," said Dr. Steven R. Steinhubl, the study's principal investigator at UK and director of cardiovascular education and clinical research at the Gill Heart Institute and a UK College of Medicine associate professor of cardiology. "It could have far-reaching implications."

"The research capacity of the cardiology division at UK has skyrocketed in the last year. Millions of dollars in research projects are under way, and we have attracted world-recognized leaders in drug discovery and development, such as Dr. Steinhubl. Leaders of technology and pharm
'"/>

Source:University of Kentucky


Page: 1 2

Related biology news :

1. A genes first kiss sets off that affair known as puberty
2. Love at first smell
3. Worlds largest rainforest drying experiment completes first phase
4. PCRM develops worlds first cruelty-free insulin assay
5. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
6. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
7. DuPonts first biologically derived polymer receives global recognition
8. Anti cancer virotherapy well tolerated in first human administration, research finds
9. Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development
10. The first impact factor for PLoS Biology ?13.9
11. Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: first administer new anti clotting technology

(Date:1/22/2015)... Inc. (NASDAQ: NXTD and NXTDW) a biometric authentication company ... of the Wocket™ smart wallet at CES 2015 in Las ... one of the "11 Hot Products at CES" in a review published ... Far" by Newseveryday.com and "The top 10 gadgets from CES 2015" by ...
(Date:1/22/2015)... 21, 2015  Analyst Report Issued by Small Cap IR. In ... that planet-wide, transactions at merchants on the leading payment cards ... of credit, debit, and prepaid cards reached 6.54 billion.  Eight ... fraudulent card usage in 2012, and credit and debit card ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... addition of the "Global Wearable Technologies Market ... Share, Overview, Trends and Forecast 2014-2020" report ... Technologies are smart devices that can be worn ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... RELEASE "Snow flea antifreeze protein" could help ... Society Scientists in Illinois and Pennsylvania are ... protein that enables billions of Canadian snow fleas to ... have practical uses in extending the storage life of ...
... transplants involve the use of stem cells from another ... major concern of the potential for acute graft-versus-host disease ... by the grafted cells against the recipient, resulting in ... are no definitive markers for predicting the development of ...
... remarkable way to protect their unborn pups. Because the ... and reactivate the ovulatory cycle, pregnant mice prevent the ... Researchers from the European Molecular Biology Laboratory (EMBL) in ... ability. A surge of the chemical signal dopamine in ...
Cached Biology News:American Chemical Society's Weekly PressPac -- July 16, 2008 2American Chemical Society's Weekly PressPac -- July 16, 2008 3American Chemical Society's Weekly PressPac -- July 16, 2008 4American Chemical Society's Weekly PressPac -- July 16, 2008 5American Chemical Society's Weekly PressPac -- July 16, 2008 6American Chemical Society's Weekly PressPac -- July 16, 2008 7American Chemical Society's Weekly PressPac -- July 16, 2008 8American Chemical Society's Weekly PressPac -- July 16, 2008 9Predicting acute GVHD by gene expression could improve liver stem cell transplant outcomes 2Pregnant mice block out unwelcome admirers to protect their pups 2
(Date:1/22/2015)... Protocol Networks brings independent technology consulting ... brand-neutral, independent consultants, Protocol Networks has recently announced its ... the years, his company has attracted several clients in ... as well as others. With the success of these ...
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project ... the legal requirements around using controlled substances in pharmaceutical ... As their international operations expand and become increasingly complex, ... as a result of the first phase of the ...
(Date:1/22/2015)... PALO ALTO, Calif. , Jan. 22. 2015  Varian Medical ... equipment and software, has been honored for its commitment to ... most sustainable companies. Varian is the highest ranked healthcare equipment ... ranking, announced today during the World Economic Forum at ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: ... areas, announced the closing of an underwritten public offering of ... to an aggregate 3,500,000 shares of common stock, at an ... The warrants have a per share exercise price of $5.00, ...
Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 2Global Compliance Service for Controlled Substances to Expand to China 2Varian Honored Among World's 100 Most Sustainable Corporations 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... Consumers cutting "experimental luxuries" such as expensive spa and anti-aging treatments ... hiring someone else to pamper them, they pamper themselves by re-creating ... a new spa facial line, meets this growing demand for high ... ...
... Plastics are everywhere in our modern world, largely due ... but lightweight and easily workable. One of their most ... than break when put under stress - is also ... "plastic flow", allows many plastics to change shape to ...
... BioInformatics, LLC,( http://www.gene2drug.com ) -- the leading market ... -- announces the publication of its latest,report, "The ... the,original social media study published jointly in 2007 ... and marketing agency,-- this report explores the impact ...
Cached Biology Technology:ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments 2ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments 3ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments 4Fast molecular rearrangements hold key to plastic's toughness 2Fast molecular rearrangements hold key to plastic's toughness 3BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World 2BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World 3
Human MFRP MAb (Clone 291218)...
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
... The NOS assay kit measures NOS activity ... to citrulline. This assay is simple, sensitive, ... be used with both crude and purified ... and reagents for 50 total reactions. Radiolabeled ...
SNARE associated protein snapin, clone MGC:2717...
Biology Products: